Trent Conelias, DDS
Oral and Maxillofacial Pathology · Virginia Beach, VANPI 1407840382
Payments from drug & device makers
Across 128 payments — averaging $67.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Straumann USA LLC$6K
- Biohorizons Implant Systems Inc.$821
- Stryker$687
- Zimvie Inc.$348
- Nobel Biocare USA$263
- Dentsply Sirona Inc$136
- plus $333 from 7 others
What the payments were for
- Food & beverage$3,72443%
- Education$2253%
- Gifts$4,69554%
- Entertainment$230%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Straumann USA LLC | 70 | $6,079 |
| Biohorizons Implant Systems Inc. | 25 | $821 |
| Stryker | 6 | $687 |
| Zimvie Inc. | 5 | $348 |
| Nobel Biocare USA | 8 | $263 |
| Dentsply Sirona Inc | 4 | $136 |
| Johnson & Johnson(2 entities) | 2 | $116 |
| Tulsa Dental Products LLC | 1 | $62 |
| Align Technology, Inc. | 3 | $49 |
| Zest Holdings, LLC | 1 | $38 |
| Salvin Dental Specialties, Inc. | 1 | $28 |
| Zimmer Biomet | 1 | $27 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few oral and maxillofacial pathology providers in Virginiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Chlorhexidine Gluconate | 291 | $1,215 |
| Amoxicillin | 257 | $588 |
| Ibuprofen | 203 | $420 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 196 | $407 |
| Azithromycin | 50 | $166 |
| Clindamycin Hcl | 14 | $93 |
| Tramadol Hcl | 36 | $46 |
Paid to pharmacies, not to this prescriber.
Other oral and maxillofacial pathology in Virginia Beach
- George KevorkianVinton$169
- Sarah GlassRichmond$29
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.